These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

617 related articles for article (PubMed ID: 25871877)

  • 21. Opposing effects of viral mediated brain expression of apolipoprotein E2 (apoE2) and apoE4 on apoE lipidation and Aβ metabolism in apoE4-targeted replacement mice.
    Hu J; Liu CC; Chen XF; Zhang YW; Xu H; Bu G
    Mol Neurodegener; 2015 Mar; 10():6. PubMed ID: 25871773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. APOE4 homozygote females are resistant to the beneficial effects of 17β-estradiol on memory and CA1 dendritic spine density in the EFAD mouse model of Alzheimer's disease.
    Taxier LR; Philippi SM; Fleischer AW; York JM; LaDu MJ; Frick KM
    Neurobiol Aging; 2022 Oct; 118():13-24. PubMed ID: 35843109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Obesity Accelerates Alzheimer-Related Pathology in
    Moser VA; Pike CJ
    eNeuro; 2017; 4(3):. PubMed ID: 28612048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential Signaling Mediated by ApoE2, ApoE3, and ApoE4 in Human Neurons Parallels Alzheimer's Disease Risk.
    Huang YA; Zhou B; Nabet AM; Wernig M; Südhof TC
    J Neurosci; 2019 Sep; 39(37):7408-7427. PubMed ID: 31331998
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: apoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology.
    Hartman RE; Wozniak DF; Nardi A; Olney JW; Sartorius L; Holtzman DM
    Exp Neurol; 2001 Aug; 170(2):326-44. PubMed ID: 11476599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Middle-aged human apoE4 targeted-replacement mice show retention deficits on a wide range of spatial memory tasks.
    Bour A; Grootendorst J; Vogel E; Kelche C; Dodart JC; Bales K; Moreau PH; Sullivan PM; Mathis C
    Behav Brain Res; 2008 Nov; 193(2):174-82. PubMed ID: 18572260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid clearance defect in ApoE4 astrocytes is reversed by epigenetic correction of endosomal pH.
    Prasad H; Rao R
    Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6640-E6649. PubMed ID: 29946028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher Neuronal Facilitation and Potentiation with APOE4 Suppressed by Angiotensin II.
    Scheinman SB; Tseng KY; Alford S; Tai LM
    Mol Neurobiol; 2024 Jan; 61(1):120-131. PubMed ID: 37589833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The detrimental effects of APOE4 on risk for Alzheimer's disease may result from altered dendritic spine density, synaptic proteins, and estrogen receptor alpha.
    Taxier LR; Philippi SM; York JM; LaDu MJ; Frick KM
    Neurobiol Aging; 2022 Apr; 112():74-86. PubMed ID: 35051676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endogenous Apolipoprotein E (ApoE) Fragmentation Is Linked to Amyloid Pathology in Transgenic Mouse Models of Alzheimer's Disease.
    Saul A; Wirths O
    Mol Neurobiol; 2017 Jan; 54(1):319-327. PubMed ID: 26742512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
    Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
    J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuronal pentraxin 1: A synaptic-derived plasma biomarker in Alzheimer's disease.
    Ma QL; Teng E; Zuo X; Jones M; Teter B; Zhao EY; Zhu C; Bilousova T; Gylys KH; Apostolova LG; LaDu MJ; Hossain MA; Frautschy SA; Cole GM
    Neurobiol Dis; 2018 Jun; 114():120-128. PubMed ID: 29501530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation.
    Liao F; Li A; Xiong M; Bien-Ly N; Jiang H; Zhang Y; Finn MB; Hoyle R; Keyser J; Lefton KB; Robinson GO; Serrano JR; Silverman AP; Guo JL; Getz J; Henne K; Leyns CE; Gallardo G; Ulrich JD; Sullivan PM; Lerner EP; Hudry E; Sweeney ZK; Dennis MS; Hyman BT; Watts RJ; Holtzman DM
    J Clin Invest; 2018 May; 128(5):2144-2155. PubMed ID: 29600961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The APOE4 allele shows opposite sex bias in microbleeds and Alzheimer's disease of humans and mice.
    Cacciottolo M; Christensen A; Moser A; Liu J; Pike CJ; Smith C; LaDu MJ; Sullivan PM; Morgan TE; Dolzhenko E; Charidimou A; Wahlund LO; Wiberg MK; Shams S; Chiang GC; ; Finch CE
    Neurobiol Aging; 2016 Jan; 37():47-57. PubMed ID: 26686669
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of chicken extract on ERK/CREB signaling is ApoE isoform-dependent.
    Yong SM; Ong QR; Siew BE; Wong BS
    Food Funct; 2014 Sep; 5(9):2043-51. PubMed ID: 25080220
    [TBL] [Abstract][Full Text] [Related]  

  • 36. APOE genotype affects metabolic and Alzheimer-related outcomes induced by Western diet in female EFAD mice.
    Christensen A; Pike CJ
    FASEB J; 2019 Mar; 33(3):4054-4066. PubMed ID: 30509127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemotherapy promotes astrocytic response to Aβ deposition, but not Aβ levels, in a mouse model of amyloid and APOE.
    Ng CAS; Biran LP; Galvano E; Mandelblatt J; Vicini S; Rebeck GW
    Neurobiol Dis; 2022 Dec; 175():105915. PubMed ID: 36336241
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models.
    Huang Y
    Biochem Soc Trans; 2011 Aug; 39(4):924-32. PubMed ID: 21787325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples.
    Chan ES; Chen C; Soong TW; Wong BS
    Neuromolecular Med; 2018 Mar; 20(1):124-132. PubMed ID: 29450841
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alzheimer's disease pathology in APOE transgenic mouse models: The Who, What, When, Where, Why, and How.
    Lewandowski CT; Maldonado Weng J; LaDu MJ
    Neurobiol Dis; 2020 Jun; 139():104811. PubMed ID: 32087290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.